Some batches of a diabetes drug manufactured by Novo Nordisk at a North Carolina plant were contaminated with bacteria, according to an inspection conducted by the U.S. Food and Drug Administration (FDA).
The bacteria were found in batches of semaglutide, the main ingredient for the company’s diabetic pill Rybelsus. The contamination was found in Novo Nordisk’s plant in Clayton, North Carolina, in July.
